1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Lepu Medical Technology (Beijing) Co., Ltd. (300003) - Product Pipeline Analysis, 2015 Update

Summary

Lepu Medical Technology (Beijing) Co., Ltd. (Lepu Medical) is a medical device company that designs, develops, manufactures, markets and distributes medical equipment for the healthcare market. The company offers interventional cardiology products, critical care products, anesthetic products and general medical care products. Lepu Medical offers interventional cardiology products such as stent, balloon, catheter, guidewire and accessoriesanesthetic products including disposable blood pressure transducer, antimicrobial central venous catheter, disposable central venous catheter kit and needle-free connector. The company also offers prosthetic heart valve, occlusion device, electrophysiology catheter, digital subtraction angiography system, GK mechanical heart valve, and IVD products. Lepu Medical is headquartered in Beijing, China.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Lepu Medical Technology (Beijing) Co., Ltd.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table Of Contents

Lepu Medical Technology (Beijing) Co., Ltd. (300003) - Product Pipeline Analysis, 2015 Update
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Lepu Medical Technology (Beijing) Co., Ltd. Company Snapshot 5
Lepu Medical Technology (Beijing) Co., Ltd. Company Overview 5
Key Information 5
Lepu Medical Technology (Beijing) Co., Ltd. Pipeline Products and Clinical Trials Overview 6
Lepu Medical Technology (Beijing) Co., Ltd. - Pipeline Analysis Overview 8
Key Facts 8
Lepu Medical Technology (Beijing) Co., Ltd. - Major Products and Services 9
Lepu Medical Technology (Beijing) Co., Ltd. Pipeline Products by Development Stage 10
Lepu Medical Technology (Beijing) Co., Ltd. Clinical Trials by Trial Status 11
Lepu Medical Technology (Beijing) Co., Ltd. Pipeline Products Overview 13
Nano+ Stent 13
Nano+ Stent Product Overview 13
Nano+ Stent Clinical Trial 14
NeoVas Bioresorbable Coronary Scaffold (BCS) 15
NeoVas Bioresorbable Coronary Scaffold (BCS) Product Overview 15
NeoVas Bioresorbable Coronary Scaffold (BCS) Clinical Trial 16
Renal Denervation System 17
Renal Denervation System Product Overview 17
Lepu Medical Technology (Beijing) Co., Ltd. - Key Competitors 18
Lepu Medical Technology (Beijing) Co., Ltd. - Locations And Subsidiaries 19
Head Office 19
Other Locations and Subsidiaries 19
Recent Developments 20
Lepu Medical Technology (Beijing) Co., Ltd., Recent Developments 20
Dec 08, 2014: Vascular Solutions Announces FDA 510(k) Clearance of VSI Radial Introducer Sheath 20
May 22, 2013: Terumo Medical Obtains Withdrawal By Vascular Solutions Of R-Band Radial Hemostasis Device 20
Feb 19, 2013: Terumo Files Patent Infringement Lawsuit Against Vascular Solutions And Lepu Medical Technology 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Lepu Medical Technology (Beijing) Co., Ltd., Key Facts 5
Lepu Medical Technology (Beijing) Co., Ltd. Pipeline Products and Clinical Trials Overview 6
Lepu Medical Technology (Beijing) Co., Ltd. Pipeline Products by Equipment Type 6
Lepu Medical Technology (Beijing) Co., Ltd. Pipeline Products by Indication 7
Lepu Medical Technology (Beijing) Co., Ltd. Clinical Trials by Trial Status 7
Lepu Medical Technology (Beijing) Co., Ltd., Key Facts 8
Lepu Medical Technology (Beijing) Co., Ltd., Major Products and Services 9
Lepu Medical Technology (Beijing) Co., Ltd. Number of Pipeline Products by Development Stage 10
Lepu Medical Technology (Beijing) Co., Ltd. Pipeline Products Summary by Development Stage 10
Lepu Medical Technology (Beijing) Co., Ltd. Clinical Trials by Trial Status 11
Lepu Medical Technology (Beijing) Co., Ltd. Clinical Trials Summary 12
Nano+ Stent - Product Status 13
Nano+ Stent - Product Description 13
Nano+ Stent - Efficacy and Safety of Nano+ Polymer-free Sirolimus-Eluting Stent in the Treatment of Patients With De Novo Lesion: A Optical Coherent Tomography Prospective, Multicenter Study 14
NeoVas Bioresorbable Coronary Scaffold (BCS) - Product Status 15
NeoVas Bioresorbable Coronary Scaffold (BCS) - Product Description 15
NeoVas Bioresorbable Coronary Scaffold (BCS) - Clinical Evaluation of a Bioresorbable Sirolimus-eluting Coronary Scaffold in the Treatment of Patients With de Novo Coronary Artery Lesion (NeoVas): a Single Arm Registry Study 16
NeoVas Bioresorbable Coronary Scaffold (BCS) - Clinical Evaluation of a Bioresorbable Sirolimus-eluting Coronary Scaffold in the Treatment of Patients with Denovo Coronary Artery Lesion (NeoVas): Randomized Controlled Trial 16
Renal Denervation System - Product Status 17
Renal Denervation System - Product Description 17
Lepu Medical Technology (Beijing) Co., Ltd., Subsidiaries 19

List of Figures
Lepu Medical Technology (Beijing) Co., Ltd. Pipeline Products by Equipment Type 7
Lepu Medical Technology (Beijing) Co., Ltd. Pipeline Products by Development Stage 10
Lepu Medical Technology (Beijing) Co., Ltd. Clinical Trials by Trial Status 11

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) - Pipeline Review, H2 2016

Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Histamine H4 Recepto ...

Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) - Pipeline Review, H2 2016

Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) - Pipeline Review, ...

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or CCR1) - Pipeline Review, H2 2016

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or CCR1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

C-C Chemokine Receptor Type 1 (HM145 or LD78 Receptor or Macrophage Inflammatory Protein 1 Alpha Receptor or RANTES R or CD191 or CCR1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘C-C ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.